Clinical Trial Update: Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial update on chemoradiotherapy for Stage III non-small cell lung cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Stage III Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-02-16